Clinical Pearls Round Up – Part I
This October, I had that wonderful opportunity to attend the Coastal Dermatology Symposium and participate in the Derm Mentors Resident of Distinction competition. This informative and enlightening conference held against the gorgeous backdrop of Monterey, California, was packed with clinically oriented lectures focusing on everything from emerging therapies in psoriasis, to proper sunscreen usa …
This October, I had that wonderful opportunity to attend the Coastal Dermatology Symposium and participate in the Derm Mentors Resident of Distinction competition. This informative and enlightening conference held against the gorgeous backdrop of Monterey, California, was packed with clinically oriented lectures focusing on everything from emerging therapies in psoriasis, to proper sunscreen usa … 
Physicians from throughout the Washington DC area recently convened at the Georgetown University MedStar Washington Hospital Center Hair Disorders Symposium, where distinguished experts in the field of hair disorders discussed the evaluation, work-up, and treatment of a wide variety of alopecias and scalp disorders. A treasure trove of clinical pearls was shared along the way, and the attendees le … 
A Recap of the JDD October Podcast
Seborrheic keratoses (SKs), though harmless, are one of the most common patient concerns. Their aesthetic impact makes them one of the most common dermatologic complaints, however treatment options are limited. In this special of the JDD podcast series, Dr. Adam Friedman discusses his group’s article “Managing Seborrheic Keratosis: Evolving Strategies an … 
Do your patients ever ask you about a dermatology treatment or concern that may seem off-the-wall?
Chances are they learned about that dermatology treatment or concern in the news. Want to know what your patients are reading about? Here are some recent news articles about dermatology in the consumer press:
Allure:
Carbonated water in beauty products
Ear pimples
How to … 
JDD Podcast Recap and Author Interview
There has been vast growth in the array of treatment options for psoriasis over the last two decades. Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing. However, patients with psoriasis are still largely undertreated. This discrepancy is explored in the paper “Discordance Be …